downloadGroupGroupnoun_press release_995423_000000 copyGroupnoun_Feed_96767_000000Group 19noun_pictures_1817522_000000Group 19Group 19noun_Photo_2085192_000000 Copynoun_presentation_2096081_000000Group 19Group Copy 7noun_webinar_692730_000000Path
Skip to main content

August 5, 2020

SEMI | SMART MedTech | NBMC | AFRL

SMART MedTech Virtual Workshop #1

From Bio-Markers to Bio-Chemical Sensors
& Physiological Relevancy

 

WORKSHOP SERIES OVERVIEW

Time

10:00 am - 12:00 pm

Location

Online, Pacific Time,
United States

SEMI | SMART MedTech | NBMC | AFRL

Agenda

Wednesday, August 5, 2020

10:00 am - 10:05 am
Melissa Grupen-Shemansky_CTO FlexTech, Exec. Dir. SEMI
Melissa Grupen-Shemansky, PhD
Executive Director FlexTech & NBMC; CTO, SEMI-NBMC

Moderator

10:05 am - 10:30 am
Cristina Davis, UC Davis
Cristina Davis, PhD
Professor and Chair, Mechanical and Aerospace Engineering Associate Director, Clinical and Translational Sciences Center, UC Davis

Opportunities and Challenges in Exhaled Breath Analysis

Biography

There is an entire field of research dedicated to the chemical analysis of exhaled breath, and the enticing promise of non-invasive medical diagnostics and monitoring. Interestingly, we know that sampling plays a key role in the metabolite content in this complex sample, and biomarker detection and identification in breath may rest on appropriate sampling and analysis protocols. There is also some evidence on how breath chemicals change over time and in response to illness, diet, overall health and exposures. There are also studies that show exogenous drugs measured in breath as well. This talk with highlight our own basic research in this area.

10:30 am - 10:55 am
Jennifer Martin & Sean Harshman (Co-Presenters)
Air Force Research Laboratory, Airman Systems Directorate

Air Force Biomarker Discovery, Wearable Devices, and the Future of Human Performance Monitoring

Jennifer's Biography | Sean's Biography

Historically, biomarker discovery efforts have focused on developing sensing strategies for disease diagnosis and prognosis. More recently, the Department of Defense has made a significant investment in wearable sensor and data analytics methods to predict physiologic and cognitive detriment with the goal of improving personnel readiness and augmenting human performance. During this presentation, a broad overview of not only biomarker discovery approaches within Air Force Research Laboratories will be provided, but also future trends and technology gaps limiting fielding of wearable devices, outlining the underpinning for potential external collaborations.

10:55 am - 11:20 am
W. Kenneth Ward, Pacific Diabetes Technologies
W. Kenneth Ward, MD
Founder & Board Chair, Pacific Diabetes Technologies

Measuring Metabolic Parameters in the Subcutaneous Interstitium

Biography

There are several compounds that interfere with accurate sensing of metabolic analytes in the subcutaneous space, including drugs and endogenous compounds. In addition, when a glucose sensor is exposed to a delivered insulin formulation, there are additional interference issues. Methods of overcoming these threats to accurate sensing will be discussed.

11:20 am - 11:45 am
Eric Van Gieson, PhD, DARPA
Eric Van Gieson, PhD
Program Manager, DARPA

DARPA’s ECHO Program: Disease Diagnosis Through Host-Response Pathway Understanding

11:45 am - 12:00 pm

Q&A

Registration

Registration Includes:

  • Live access to four (4) webinars
  • Post-webinar access to recordings and presentations
     

Member Price: $199

Non-Member Price: $399

Non-Member Price for Government, Military, and Academia: $249 
(Contact Michelle Fabiano at mfabiano@semi.org for discount code. Must have a valid .gov, .mil or .edu email address)